Search Results 1801-1810 of 21423 for anti-TNF drugs

1. Thalidomide (Oral Route) Description and Brand Names - Mayo Clinic

   This medicine is also used to treat moderate to severe new lesions of leprosy and as maintenance treatment to prevent and keep erythema nodosum leprosum (skin ...

2. Thalidomide (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

3. Tramadol And Acetaminophen (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

4. A Study to Evaluate the Use of Adipose-derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis - Mayo Clinic

   Patients receiving treatment with hematopoietic growth factors or anti-vasculogenesis or anti-angiogenesis treatment (e.g., anti-VEGF). Patients requiring ...

5. Mayo Clinic Minute: Treatment for uterine fibroids without surgery

   Elizabeth Stewart, a Mayo Clinic gynecologist and researcher, recently published a review on these approved fibroid medications. They are called oral ...

6. Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

   Patient with aggressive NHL must have received prior therapy - at a minimum: Anti-CD20 monoclonal antibody unless tumor is CD20 negative; and; An ...

7. Phentermine And Topiramate (Oral Route) Precautions - Mayo Clinic

   You will also be required to have a pregnancy test every month during your treatment. If you miss a period while you are using this medicine, tell your doctor ...

8. Zonisamide (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

9. Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant - Mayo Clinic

   ... anti-human leukocyte antigen (HLA) antibody specific for their deceased donor. It is our hypothesis that blockade of terminal complement activation with ...

10. A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma - Mayo Clinic

    ... treatment regimens (including anti-CD20 mAb and an alkylating agent). For MZL patients: Previously received at least 2 prior lines of systemic therapy ...